Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke
TREAT-AIS
1 other identifier
observational
3,000
1 country
1
Brief Summary
Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke is a multi-centers registration. It starts in Jan 2019. The key items in the registration form include basic demographic profiles, past medical history, time of stroke onset, stroke severity (NIH stroke scale), whether to have rt-PA treatment, pre-EVT imaging, type of devices, status of recanalization, complication and other associated parameters for EVT, and 3 months post stroke outcome. The study also includes a standardized imaging analysis for the quantification of the de-identified imaging data from participates. In summary, the registry will provide the valuable information for AIS patients receiving EVT in Twain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
March 6, 2022
CompletedFirst Posted
Study publicly available on registry
March 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
March 15, 2022
March 1, 2022
12 years
March 6, 2022
March 6, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Functional outcome
Functional outcome by modified Rankin scale at 90 days post-stroke
90 days
Study Arms (1)
EVT group
Patients who received endovascular thrombectomy for acute ischemic stroke with large vessel occlusion.
Interventions
Timely thrombectomy for acute ischemic stroke patients with large vessel occlusion by either stent retriever, thrombosuction, others, or combination methods.
Eligibility Criteria
Acute ischemic stroke caused by intracranial large vessel occlusion who can be treated within 24 hours of stroke onset.
You may qualify if:
- Acute ischemic stroke caused by intracranial large vessel occlusion
- Can be treated within 24 hours of stroke onset.
- Large vessel occlusion demonstrated by magnetic resonance imaging angiography (MRA), computed tomography angiography (CTA) or digital substraction angiography (DSA).
- Pre-stroke independence (modified Rankin Scale 0-2).
You may not qualify if:
- Other cause of stroke, such as intracranial hemorrhage.
- Not underwent endovascular thrombectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sung-Chun Tang, MD, PhD
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2022
First Posted
March 15, 2022
Study Start
January 1, 2019
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
March 15, 2022
Record last verified: 2022-03